Market Tracker

04/28 5:16pm ET

Prothena Corporation PLC (NASDAQ:PRTA)

54.13
Delayed Data
As of Apr 28
 +0.12 / +0.22%
Today’s Change
33.53
Today|||52-Week Range
68.18
+10.04%
Year-to-Date

Today’s Trading

Previous close54.01
Today’s open54.00
Day’s range52.82 - 54.61
Volume589,133
Average volume (3 months)306,691
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-75.19%
Earnings growth (this year)-7.03%
Earnings growth (next 5 years)-15.83%
Revenue growth (last year)-34.35%
P/E ratioNM
Price/Sales1,601.64
Price/Book5.15

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.75+1.28%
SRPTSarepta Therapeutics...+1.54+4.44%
TBPHTheravance Biopharma...-0.32-0.79%
PCRXPacira Pharmaceutica...+0.50+1.04%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$1.39
Annual revenue (last year)$1.1M
Annual profit (last year)-$160.1M
Net profit margin-15,176.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Financial Officer
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts